Soleno Therapeutics (SLNO) Treasury Shares (2016 - 2026)
Soleno Therapeutics (SLNO) reported Treasury Shares of $1.2 million for Q1 2026, up 220.05% year-over-year from $361991.0 in Q1 2025, and up 161.35% on a QoQ basis from $443291.0 in Q4 2025.
Soleno Therapeutics (SLNO) has 9 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Treasury Shares rose 220.05% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 220.05% YoY) and the FY2025 annual result came in at $443291.0, down 52.83% from the prior year.
- Treasury Shares improved to $1.2 million in Q1 2026 per SLNO's latest filing, from $443291.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.2 million in Q1 2026 and bottomed at $9534.0 in Q1 2023.
- The 5-year median for Treasury Shares is $361991.0 (2025), against an average of $409174.1.
- The widest annual swing landed in 2023, when Treasury Shares sank 96.7%; it then jumped 5950.37% in 2024.
- Tracing SLNO's Treasury Shares over 5 years: stood at $19068.0 in 2022, then dropped by 18.53% to $15534.0 in 2023, then jumped by 5950.37% to $939865.0 in 2024, then sank by 52.83% to $443291.0 in 2025, then jumped by 161.35% to $1.2 million in 2026.
- Per Business Quant, the three latest SLNO Treasury Shares figures stand at $1.2 million (Q1 2026), $443291.0 (Q4 2025), and $469769.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 443,291.00 |
| Dec 31, 2025 | 443,291.00 |
| Sep 30, 2025 | 469,769.00 |
| Sep 30, 2025 | 469,769.00 |
| Jun 30, 2025 | 468,457.00 |
| Jun 30, 2025 | 468,457.00 |
| Mar 31, 2025 | 361,991.00 |
| Mar 31, 2025 | 361,991.00 |
| Dec 31, 2024 | 939,865.00 |
| Dec 31, 2024 | 939,865.00 |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 256,030.00 |
| Jun 30, 2024 | 256,030.00 |
| Mar 31, 2024 | 299,280.00 |
| Mar 31, 2024 | 299,280.00 |
| Dec 31, 2023 | 15,534.00 |
| Dec 31, 2023 | 15,534.00 |
| Sep 30, 2023 | 424,244.00 |
| Sep 30, 2023 | 424,244.00 |
| Jun 30, 2023 | 424,244.00 |
| Jun 30, 2023 | 424,244.00 |
| Mar 31, 2023 | 9,534.00 |
| Mar 31, 2023 | 9,534.00 |
| Dec 31, 2022 | 19,068.00 |
| Dec 31, 2022 | 19,068.00 |
| Sep 30, 2022 | 19,068.00 |
| Sep 30, 2022 | 19,068.00 |
| Jun 30, 2022 | 286,000.00 |
| Jun 30, 2022 | 286,000.00 |
| Mar 31, 2022 | 288,500.00 |
| Mar 31, 2022 | 288,500.00 |
| Dec 31, 2021 | 29,050.00 |
| Dec 31, 2021 | 29,050.00 |
| Sep 30, 2021 | 435,750.00 |
| Sep 30, 2021 | 435,750.00 |
| Jun 30, 2021 | 435,750.00 |
| Jun 30, 2021 | 435,750.00 |
| Mar 31, 2021 | 435,750.00 |
| Mar 31, 2021 | 435,750.00 |
| Dec 31, 2020 | 38,733.00 |
| Dec 31, 2020 | 38,733.00 |
| Sep 30, 2020 | 581,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Jun 30, 2020 | 591,000.00 |
| Jun 30, 2020 | 591,000.00 |
| Mar 31, 2020 | 658,500.00 |
| Mar 31, 2020 | 658,500.00 |
| Dec 31, 2017 | 7,780.00 |
| Dec 31, 2017 | 7,780.00 |
| Dec 31, 2016 | 7,780.00 |
| Dec 31, 2016 | 7,780.00 |